• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

WHO Director-General's opening remarks at the COVID-19 media briefing referencing monkeypox – 12 July 2022

Mary Wilson

Well-known member
12 July 2022

... On Monkeypox, there are now 9,200 cases in 63 countries.

The Emergency Committee for monkeypox will reconvene next week and look at trends, how effective the counter-measures are and make recommendations for what countries and communities should do to tackle the outbreak.

In the meantime, the multi-pronged approach continues:

First, WHO is working closely with civil society and LGBTIQ+ community, especially to tackle the stigma around the virus and spread information so people can stay safe.

Second, WHO continues to work with countries and vaccine manufacturers to coordinate the sharing of vaccines, which are currently scarce.

Third, WHO continues to work with countries and experts to drive forward research and development.

On Sunday and Monday, the National Institute for Biomedical Research in the Democratic Republic of Congo, the National Institute of Health and Medical Research and the National Institute of Allergy and Infectious Diseases in collaboration with WHO, convened researchers and experts in trials worldwide to develop consensus on a global CORE protocol for the evaluation of treatments for monkeypox.

I again stress that we must work to stop onward transmission and advise governments to implement contact tracing to help track and stem the virus as well as to assist people in isolation. ...

https://www.who.int/director-genera...-at-the-covid-19-media-briefing--12-july-2022
 
Back
Top